Anthony G. Quinn - President & CEO, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SYRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anthony G. Quinn since 10/5/2023

Holdings reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 551K $309K $0.56 Mar 16, 2022 Direct
Common Stock 266K $149K $0.56 Mar 16, 2022 By trusts
Employee Stock Option (right to buy) 350K Feb 17, 2022 Direct Common Stock

Transactions reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.